Persistence of DNMT3A does not influence clinical outcome in acute myeloid leukaemia

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

269 Downloads (Pure)

Original language	English
Pages (from-to)	185-186
Number of pages	2
Journal	British Journal of Haematology
Volume	175
Issue number	2
Early online date	08 Sept 2016
DOIs	https://doi.org/10.1111/bjh.14296
Publication status	Published - Oct 2016

Access to Document

Persistence of DNMT3A does not influence clinical outcome in acute myeloid leukaemia
© 2016 John Wiley & Sons Ltd This is the pre-peer reviewed version of the following article: Mills, K. (2016), Persistence of DNMT3A does not influence clinical outcome in acute myeloid leukaemia. British Journal of Haematology., which has been published in final form at [http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14296/abstract. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Accepted author manuscript, 101 KBLicence: Unspecified

@article{1742b57c166e4430bd4fc05825c82a21,

title = "Persistence of DNMT3A does not influence clinical outcome in acute myeloid leukaemia",

author = "Ken Mills",

year = "2016",

month = oct,

doi = "10.1111/bjh.14296",

language = "English",

volume = "175",

pages = "185--186",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

number = "2",

}